Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (964)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
143
Price
$578.14
Total Value
$82.67K
Shares Held After
48,675
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
307
Price
$577.06
Total Value
$177.16K
Shares Held After
48,818
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$576.14
Total Value
$368.73K
Shares Held After
49,125
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
248
Price
$575.38
Total Value
$142.69K
Shares Held After
49,765
% of Holdings
0.5%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
324
Price
$7.95
Total Value
$2.58K
Shares Held After
50,268
% of Holdings
0.6%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,437
Price
$15.00
Total Value
$36.55K
Shares Held After
0
% of Holdings
100.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
200
Price
$163.32
Total Value
$32.66K
Shares Held After
13,666
% of Holdings
1.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
216
Price
$162.48
Total Value
$35.10K
Shares Held After
13,866
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
274
Price
$161.41
Total Value
$44.23K
Shares Held After
14,082
% of Holdings
1.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
226
Price
$160.55
Total Value
$36.28K
Shares Held After
14,356
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
52
Price
$159.38
Total Value
$8.29K
Shares Held After
14,582
% of Holdings
0.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
32
Price
$158.46
Total Value
$5.07K
Shares Held After
14,634
% of Holdings
0.2%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
15,600
Price
$73.01
Total Value
$1.14M
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
25,040
Price
$6.43
Total Value
$161.01K
Shares Held After
362,729
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
PATUSKY CHRISTOPHER — Director
Shares
1,000
Price
$578.88
Total Value
$578.88K
Shares Held After
1,490
% of Holdings
40.2%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
53,867
Price
$0.73
Total Value
$39.32K
Shares Held After
143,185
% of Holdings
27.3%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
102,057
Price
$3.45
Total Value
$351.66K
Shares Held After
12,033,896
% of Holdings
0.8%
Scholar Rock Holding Corp (SRRK)
Vaishnaw Akshay — Director
Shares
12,246
Price
$49.57
Total Value
$607.09K
Shares Held After
630,542
% of Holdings
1.9%
Scholar Rock Holding Corp (SRRK)
Hallal David — Director
Shares
30,615
Price
$49.57
Total Value
$1.52M
Shares Held After
1,639,034
% of Holdings
1.8%
Scholar Rock Holding Corp (SRRK)
Woods Keith — Chief Operating Officer
Shares
10,220
Price
$49.57
Total Value
$506.65K
Shares Held After
620,055
% of Holdings
1.6%
Scholar Rock Holding Corp (SRRK)
Sinha Vikas — Chief Financial Officer
Shares
10,410
Price
$49.57
Total Value
$516.07K
Shares Held After
619,856
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
Gline Matthew — Director
Shares
289,774
Price
$29.16
Total Value
$8.45M
Shares Held After
16,736,116
% of Holdings
1.7%
COGNITION THERAPEUTICS INC (CGTX)
Ricciardi Lisa — Director
Shares
9,175
Price
$1.10
Total Value
$10.09K
Shares Held After
1,715,851
% of Holdings
0.5%
COGNITION THERAPEUTICS INC (CGTX)
Doyle John Brendan — Chief Financial Officer
Shares
10,000
Price
$1.13
Total Value
$11.30K
Shares Held After
627,509
% of Holdings
1.6%
COGNITION THERAPEUTICS INC (CGTX)
Caggiano Anthony — Chief Medical Officer
Shares
10,000
Price
$1.11
Total Value
$11.10K
Shares Held After
874,906
% of Holdings
1.1%
Milestone Pharmaceuticals Inc. (MIST)
Oliveto Joseph — Director
Shares
36,500
Price
$2.26
Total Value
$82.49K
Shares Held After
446,244
% of Holdings
7.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
12
Price
$164.12
Total Value
$1.97K
Shares Held After
14,666
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
36
Price
$163.21
Total Value
$5.88K
Shares Held After
14,678
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
76
Price
$162.26
Total Value
$12.33K
Shares Held After
14,714
% of Holdings
0.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
240
Price
$161.61
Total Value
$38.79K
Shares Held After
14,790
% of Holdings
1.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
201
Price
$160.35
Total Value
$32.23K
Shares Held After
15,030
% of Holdings
1.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
219
Price
$159.81
Total Value
$35.00K
Shares Held After
15,231
% of Holdings
1.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
216
Price
$158.28
Total Value
$34.19K
Shares Held After
15,450
% of Holdings
1.4%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
2,292
Price
$28.60
Total Value
$65.56K
Shares Held After
139,792
% of Holdings
1.6%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
7,748
Price
$6.40
Total Value
$49.59K
Shares Held After
387,769
% of Holdings
2.0%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
2,000
Price
$90.00
Total Value
$180.00K
Shares Held After
175,371
% of Holdings
1.1%
IONIS PHARMACEUTICALS INC (IONS)
Birchler Brian — EVP, Corp and Development Ops
Shares
973
Price
$75.04
Total Value
$73.02K
Shares Held After
67,500
% of Holdings
1.4%
IONIS PHARMACEUTICALS INC (IONS)
Jenne Kyle — EVP, Chf GL Pdt Str Ofcr
Shares
4,902
Price
$75.17
Total Value
$368.49K
Shares Held After
23,713
% of Holdings
17.1%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
5,619
Price
$74.56
Total Value
$418.95K
Shares Held After
46,535
% of Holdings
10.8%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
1,820
Price
$2.65
Total Value
$4.82K
Shares Held After
104,645
% of Holdings
1.7%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
2,097
Price
$27.49
Total Value
$57.65K
Shares Held After
295,157
% of Holdings
0.7%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
686
Price
$27.01
Total Value
$18.53K
Shares Held After
297,254
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
87
Price
$27.49
Total Value
$2.39K
Shares Held After
392,627
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
29
Price
$27.01
Total Value
$783.29
Shares Held After
392,714
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
225
Price
$27.49
Total Value
$6.19K
Shares Held After
190,165
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
73
Price
$27.01
Total Value
$1.97K
Shares Held After
190,390
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
6,657
Price
$20.06
Total Value
$133.52K
Shares Held After
4,544,773
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
11,116
Price
$21.10
Total Value
$234.59K
Shares Held After
4,551,430
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
7,575
Price
$27.49
Total Value
$208.24K
Shares Held After
1,630,564
% of Holdings
0.5%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
2,477
Price
$27.01
Total Value
$66.90K
Shares Held After
1,638,139
% of Holdings
0.2%
Showing 251–300 of 964 transactions (page 6 of 20)